Kelly MacDonald compensation by year
DYNAVAX TECHNOLOGIES Summary Compensation Table · all 3 fiscal years held| Component | FY2022 | FY2023 | FY2024 |
|---|---|---|---|
| Salary | $425,000 | $475,000 | $480,098 |
| Bonus | $0 | $0 | $6,642 |
| Stock awards | $389,760 | $547,500 | $1,379,435 |
| Option awards | $729,240 | $729,750 | $513,331 |
| Non-equity incentive | $240,550 | $301,625 | $239,408 |
| Pension and deferred compensation | $0 | $0 | $0 |
| All other | $8,716 | $11,930 | $7,353 |
| Total | $1,793,266 | $2,065,805 | $2,626,267 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DYNAVAX TECHNOLOGIES CORP DEF 14A filed April 17, 2025, accession 0000930413-25-001273, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2024 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 46,430 | $592,911 | — |
| RSU | 46,430 | $592,911 | — |
| PSU | 30,000 | $383,100 | — |
| PSU | 16,000 | $204,320 | — |
| RSU | 5,333 | $68,102 | — |
| Option | 5,028 | — | $12.74 |
| Option | 65,000 | — | $12.48 |
| Option | 38,890 | — | $11.12 |
Per the Outstanding Equity Awards at Fiscal Year-End table in DYNAVAX TECHNOLOGIES CORP's FY2024 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments DYNAVAX TECHNOLOGIES discloses, by trigger · FY2024| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control, no termination | — | $1,331,603 | — | $1,331,603 |
| Change in control and involuntary termination | $1,174,500 | $1,924,514 | $36,377 | $3,135,391 |
| Involuntary termination without cause | $783,000 | $180,892 | $24,252 | $988,144 |
Per the Potential Payments Upon Termination or Change in Control table in DYNAVAX TECHNOLOGIES CORP's FY2024 proxy. Estimates as the company printed them; a dash means it printed no figure.
DYNAVAX TECHNOLOGIES’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Ryan Spencer | Chief Executive Officer and Director | $8,210,775 |
| David Novack | President and Chief Operating Officer | $3,731,687 |
| John Slebir | Senior Vice President and General Counsel | $2,847,447 |
| Kelly MacDonald · this page | Senior Vice President and Chief Financial Officer | $2,626,267 |
| Robert Janssen | Chief Medical Officer and Senior Vice President | $2,283,533 |
The full DYNAVAX TECHNOLOGIES compensation record
free company briefThis page is one person within DYNAVAX TECHNOLOGIES's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order DYNAVAX TECHNOLOGIES's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are DYNAVAX TECHNOLOGIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat